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QRS Morphology
Is Equally Important!
We read with great interest the TARGET (Targeted Left Ven-
tricular Lead Placement to Guide Cardiac Resynchronization
Therapy) study by Khan et al. (1), a randomized controlled trial
with targeted left ventricular (LV) lead placement to guide cardiac
resynchronization therapy. The results of the study are promising
and do emphasize the importance of the location of the LV lead in
relation to the latest segment of contraction. However, many
conventional variables have not been identified in the study, and
more data are needed to support the conclusions of the study.
Morphology of the QRS complex (left bundle branch block vs.
right bundle branch block vs. nonspecific intraventricular conduc-
tion delay) has not been reported in the study. Many previous
studies have consistently shown that QRS morphology is one of
the most important predictors of response (2). The distribution of
left bundle branch block between both groups should be identified
as it can potentially influence the results.
It will be interesting to see if there is a correlation between the
QRS morphology and axis with the latest segment of contraction
in this study. It is postulated that QRS morphology and frontal
axis can predict the latest segment of activation; whether it would
predict the latest segment of mechanical contraction is unknown
(3). Khan et al. (1) do have the unique opportunity to evaluate this
concept in their study population. Nearly one-half (47%) of the
patients in the control group ended up having a concordant LV
lead location in relation to the segment of latest contraction. It
would be very helpful to identify the surface electrocardiogram
characteristics (QRS morphology and axis) of this subgroup and
compare them with those of patients in whom the LV lead was not
concordant. If it is possible to predict the area of latest contraction,with reasonable accuracy, using surface electrocardiogram mor-
phology, it would make the concept of “targeting LV lead” much
easier and widely acceptable, without the use of the more sophis-
ticated radial strain measurement.
Total scar burden, an important variable in predicting outcomes
in cardiac resynchronization therapy (4) has not been reported in
his study. Patients with higher scar burden are intuitively more
ikely to have a scar at the LV lead site and are less likely to have
concordant LV lead (more remote or adjacent location), thereby
ignificantly influencing the results. The mean total scar burden in
oth groups should be reported in the study to support the
onclusions.
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Reply
We are grateful for the comments and interest shown by Drs.
Reddy and Lakkireddy with respect to our recent publication of
the TARGET (Targeted Left Ventricular Lead Placement to
Guide Cardiac Resynchronization Therapy) study (1) regarding
targeted left ventricular (LV) lead placement to guide cardiac
resynchronization therapy (CRT). We do not believe that there are
robust data to justify the title of their letter and have addressed the
specific points below.
First, the morphology of the QRS complex is not, as of yet, part
of the guidelines for patients who should be recommended CRT
even though, as pointed out by the authors, a number of studies
have shown that it is an important determinant of response (2).
The centers recruiting for the study routinely implant patients with
only baseline left bundle branch block (LBBB) morphology.
Reflecting this, there were only 2 patients who had non-LBBB
morphology, distributed equally in each group. In both patients,
the electrocardiogram showed right bundle branch block morphol-
ogy, the latest segment of activation was in the inferoseptum, the
final lead position was remote, and both patients were CRT
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groups did not influence the primary endpoint of the study.
Second, the concept of using the baseline electrocardiogram to
identify the optimal segment for LV lead pacing is interesting. The
most important conclusion from the TARGET study is that the
latest site of mechanical activation and distribution of scar are
related to long-term outcomes. The electrocardiogram can inform
regarding the latest site of electrical activation and scar, but as yet
there is no evidence that it offers sufficient sensitivity to predict the
response to CRT. We have not had the opportunity yet to explore
this with the TARGET dataset, and we are grateful to the authors
for bringing this to our attention as a focus for future study.
Third, total scar burden is indeed a key determinant of outcome
after CRT (3), and its role in the TARGET population is the
focus of continuing study by our group. Speckle-tracking echocar-
diography is the main modality used in the study, and its utility in
assessing total scar burden in a CRT population is not well
reported. We have recently reported, in abstract form, the corre-
lation of speckle-tracking echocardiography to total scar burden as
defined by magnetic resonance imaging. We are continuing
analysis of our data to assess the use of speckle-tracking echocar-
diography to delineate LV scar, but considered it premature to
report these data pending further validation.Fakhar Z. Khan, MA
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